Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
financial performance and ensuring that key financial targets are met. Key responsibilities: Partner with senior management to develop budgets, monitor performance and recommend corrective actions. Provide
-
, methodological development, and the analysis and reporting of experimental data. You will primarily support the insectary at the Jenner Institute aiming for the assessment of new target antigens as vaccine
-
for their expression in plant colonizing bacteria and integrating them into the chromosomes of appropriate chassis. Control systems will be designed to restrict expression to target plants and ensure optimal expression
-
proposals, conducting site visits, and providing exceptional customer service throughout, ensuring sales targets are met. You will act as duty manager during events - including evenings and weekends
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
the possibility of making “universal” vaccines by targeting these epitopes. We have validated this methodology for the influenza virus (https://www.nature.com/articles/s41467-018-06228-8) and the technology has
-
interpret high-resolution datasets that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil
-
, inclusive, and targeted to the right audiences. About You We're looking for someone who brings energy, strategic thinking, and attention to detail. You’ll need to demonstrate: Proven experience producing
-
that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. This is a unique opportunity to work at the cutting edge of translational
-
initiative, established in 2024, is a collaboration between the University of Oxford and GlaxoSmithKline (GSK) aimed at identifying molecular vulnerabilities in precancers and developing targeted interventions